Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ESSA Pharma Inc.

    NASDAQ: EPIX · Real-Time Price · USD
    1.67
    -0.03 (-1.76%)
    At close: Jun 17, 2025, 3:59 PM
    1.69
    1.20%
    After-hours: Jun 17, 2025, 04:43 PM EDT

    ESSA Pharma Statistics

    Share Statistics

    ESSA Pharma has 44.39M shares outstanding. The number of shares has increased by 0.06% in one year.

    Shares Outstanding

    n/a
    		 44.39M

    Shares Change (YoY)

    n/a
    		 0.06%

    Shares Change (QoQ)

    n/a
    		 0.04%

    Owned by Institutions (%)

    n/a
    		 74.21%

    Shares Floating

    n/a
    		 41.72M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,909

    FTD / Avg. Volume

    n/a
    		 2.54%

    Short Selling Information

    The latest short interest is 686.09K, so 1.55% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 686.09K

    Short % of Shares Out

    n/a
    		 1.55%

    Short % of Float

    n/a
    		 1.98%

    Short Ratio (days to cover)

    n/a
    		 6.13

    Valuation Ratios

    The PE ratio is -9.4 and the forward PE ratio is -3.41. ESSA Pharma's PEG ratio is -1.41.

    PE Ratio

    n/a
    		 -9.4

    Forward PE

    n/a
    		 -3.41

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.09

    P/FCF Ratio

    n/a
    		 -11.81

    PEG Ratio

    n/a
    		 -1.41
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ESSA Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 38.64, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 38.64

    Quick Ratio

    n/a
    		 38.64

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-815,509.17

    Employee Count

    n/a
    		 35

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -65.71% in the last 52 weeks. The beta is 1.58, so ESSA Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.58

    52-Week Price Change

    n/a
    		 -65.71%

    50-Day Moving Average

    n/a
    		 1.69

    200-Day Moving Average

    n/a
    		 2.69

    Relative Strength Index (RSI)

    n/a
    		 51.29

    Average Volume (20 Days)

    n/a
    		 153,857

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -34.42M

    Net Income

    n/a
    		 -28.54M

    EBITDA

    n/a
    		 -28.45M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.64
    Full Income Statement

    Balance Sheet

    The company has 103.71M in cash and 329.26K in debt, giving a net cash position of 103.38M.

    Cash & Cash Equivalents

    n/a
    		 103.71M

    Total Debt

    n/a
    		 329.26K

    Net Cash

    n/a
    		 103.38M

    Retained Earnings

    n/a
    		 n/a

    Total Assets

    n/a
    		 115.42M

    Working Capital

    n/a
    		 86.72M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -22.72M and capital expenditures 0, giving a free cash flow of -22.72M.

    Operating Cash Flow

    n/a
    		 -22.72M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -22.72M

    FCF Per Share

    n/a
    		 -0.51
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    EPIX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EPIX is $2, which is 19% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $2

    Price Target Difference

    n/a
    		 19%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 25, 2018. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Apr 25, 2018

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 21.47

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist